Pharmacogenetics of nonsteroidal anti-inflammatory drugs
Authors:
- W L PettitWPW L Pettit
- S HarirforooshSHS Harirforoosh
- 9 October 2012
- journal article
- review article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 12 (6) , 462-467
Abstract
With the beginning of the Human Genome Project, an emerging field of science was brought to the forefront of the pharmaceutical community. Pharmacogenetics facilitates optimization of the current patient-centered care model and pharmacotherapy as a whole. Utilizing these ever-expanding branches of science to nonsteroidal anti-inflammatory drugs (NSAIDs) can provide novel opportunities to affect patient care. With a wide range of NSAID choices available as treatment options for relieving pain and/or reducing inflammation or fever, a more systematic way of selecting the ideal agent for the patients based upon their genetic information could spare them from a potentially permanent health-care condition. Furthermore, if a patient possesses or lacks certain alleles, serious adverse events can be anticipated and avoided. The tailoring of drug therapy can be achieved using the published data and cutting-edge genetic testing to attain a higher standard of care for patients.Keywords
This publication has 57 references indexed in Scilit:
- Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal AdenomaGastroenterology, 2009
- The pharmacogenetics of analgesiaExpert Opinion on Pharmacotherapy, 2007
- Safety and Efficacy of Statins in AsiansThe American Journal of Cardiology, 2007
- Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and CelecoxibClinical Pharmacokinetics, 2003
- Nonsteroidal Anti-Inflammatory Drugs and Heart FailureDrugs, 2003
- Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenaseBritish Journal of Clinical Pharmacology, 2002
- Polymorphic Variants (CYP2C9*3 and CYP2C9*5) and the F114L Active Site Mutation of CYP2C9: Effect on Atypical Kinetic Metabolism ProfilesDrug Metabolism and Disposition, 2002
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Clinical Pharmacokinetics of IbuprofenClinical Pharmacokinetics, 1998
- Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionThe Journal of Clinical Pharmacology, 1991